|
Market Closed -
Toronto S.E.
10:18:01 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | -25.00% |
|
-25.00% | -40.00% |
| Market Cap | 918K 658K 589K 542K 491K 62.5M 936K 6.47M 2.6M 32.87M 2.47M 2.42M 104M | P/E 2024 |
-40.5x | P/E 2025 | -5.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.92M 1.37M 1.23M 1.13M 1.03M 130M 1.95M 13.5M 5.42M 68.65M 5.16M 5.05M 216M | EV / Sales 2024 |
929,496,174x | EV / Sales 2025 | - |
| Free-Float |
53.08% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GENX | Delayed | |
OTC Markets
| GENPF | Delayed |
| 1 day | -25.00% | ||
| 1 week | -25.00% | ||
| Current month | -25.00% | ||
| 1 month | -25.00% | ||
| 6 months | -25.00% | ||
| Current year | -40.00% |
| 1 week | 0.02 | 0.02 | |
| 1 month | 0.02 | 0.02 | |
| Current year | 0.02 | 0.02 | |
| 1 year | 0.02 | 0.03 | |
| 3 years | 0.02 | 0.09 | |
| 5 years | 0.02 | 0.19 | |
| 10 years | 0.01 | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 57 | 2018-08-02 |
Raylen Tamayo
DFI | Director of Finance/CFO | - | 2026-05-03 |
Mahmoud Aziz
PSD | President | - | 2021-05-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Pirooz
BRD | Director/Board Member | 57 | 2018-08-02 |
Jamie Lewin
BRD | Director/Board Member | 76 | 2019-03-10 |
Kevin Bottomley
BRD | Director/Board Member | 48 | 2019-09-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/25 | Option | Chairman | 1,000,000 | 1.6885% | ||
| 9/9/25 | Option | Chairman | 1,000,000 | 1.6885% | ||
| 9/9/25 | Option | Chief Executive Officer | 1,000,000 | 1.6885% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -25.00% | -25.00% | -50.00% | -62.50% | 658K | ||
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | ||
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | ||
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | ||
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | ||
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | ||
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | ||
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | ||
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | ||
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | ||
| Average | -0.94% | +5.31% | +36.93% | +68.57% | 426.19B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0 0 0 0 0 0.28 0 0.03 0.01 0.15 0.01 0.01 0.46 | - |
| Net income | -73.2K -52.46K -46.98K -43.22K -39.16K -4.98M -74.57K -515K -207K -2.62M -197K -193K -8.26M | -335K -240K -215K -198K -179K -22.8M -341K -2.36M -947K -11.99M -901K -882K -37.82M |
| Net Debt | 804K 576K 516K 475K 430K 54.73M 819K 5.66M 2.27M 28.79M 2.16M 2.12M 90.78M | 999K 716K 641K 590K 535K 68M 1.02M 7.04M 2.82M 35.77M 2.69M 2.63M 113M |
Employees
4,000
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- GENX Stock
Select your edition
All financial news and data tailored to specific country editions

















